AIMP1P1

Across TCGA pan-cancer cohorts, AIMP1P1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated AIMP1P1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher AIMP1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AIMP1P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and KIRC show a favorable association.

OV, LIHC, and BLCA are the cancer types where AIMP1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	IV	0.304	0.585	<.001	68	view →
LIHC	DFS	Tertile	All	0.249	0.576	<.001	48	view →
BLCA	DFS	Tertile	III,IV	0.161	0.358	.010	45	view →
UCEC	DFS	Tertile	All	0.737	0.858	.001	30	view →
LGG	DFS	Tertile	All	0.177	0.464	.009	21	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
SKCM	OS	Tertile	All	0.461	0.294	.010	9	view →
STAD	DFS	Tertile	IV	0.193	0.746	.039	7	view →
THYM	DFS	Tertile	All	0.734	0.920	.033	6	view →
KIRC	DFS	Tertile	All	0.942	0.857	.022	6	view →
THCA	OS	Tertile	All	0.576	0.958	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

AIMP1P1–OV (DFS)

Open the OV breakdown →